Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Talen Energy Corp V.TLN


Primary Symbol: TLN

Talen Energy Corporation is an independent power producer and energy infrastructure company. The Company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States, including 2.2 gigawatts of nuclear power and a significant dispatchable fossil fleet. It produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic and Montana. Its PJM segment is engaged in electricity generation, marketing activities, commodity risk and fuel management within the PJM RTO or ISO markets and comprises Susquehanna and its natural gas and coal generation facilities. Its Other segment includes the operating and marketing activities of Montana’s proportionate share of the Colstrip Units in the WECC market, the operating activities of Nautilus, and other development activities. It owns 100% of Nautilus Cryptomine (Nautilus), a 200-megawatt bitcoin mining facility in Berwick.


NDAQ:TLN - Post by User

Bullboard Posts
Post by everswannon Feb 06, 2009 11:04am
101 Views
Post# 15758155

Risk reward for buyer

Risk reward for buyer
Reward

Combine 7 years sales (monopoly guaranteed by Orphan drug status) X 3,5 billion = 24.5 Billions


Risk to assume

TLN has no debt
Clinical risks and investment to be done about 130 million
Purchasing TLN 70 millon
= 200 millions

That's  a 1 for 100 ROI (ruff numbers)

Alternative investments

If you go out and develop a new drug it will cost you 400-500 millions from stracth
If you have a PII compound there is about 200-300 left to burn

For the same price, 200 millions, you get 3 drugs, 3 chances of recuperating invesment and making profit assuming that one of 3 is approved.

Pretty good perspective for buyer.
Bullboard Posts